4.5 Article

Patterns and correlates of cannabidiol product and marijuana co-use in a sample of US young adults

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Pharmacology & Pharmacy

Use and Perceptions of Cannabidiol Products in Canada and in the United States

Samantha Goodman et al.

Summary: CBD product use is more prevalent in the United States than in Canada, primarily for managing self-reported health conditions such as pain, anxiety, and depression. Over half of consumers believe that CBD oil is beneficial for health.

CANNABIS AND CANNABINOID RESEARCH (2022)

Article Psychiatry

A Multiple Correspondence Analysis of Patterns of CBD Use in Hemp and Marijuana Users

Joseph R. Vilches et al.

Summary: The study found that co-use of CBD and marijuana is common, with differences in CBD administration and duration of use between CBD+MJ users and those using only CBD. Multiple correspondence analysis revealed that CBD+MJ users are typically female, have lower educational attainment, use CBD for medical reasons, and exhibit differences in smoking-related behaviors.

FRONTIERS IN PSYCHIATRY (2021)

Review Health Care Sciences & Services

Cannabidiol Interactions with Medications, Illicit Substances, and Alcohol: a Comprehensive Review

Premalatha Balachandran et al.

Summary: CBD, a non-intoxicating phytocannabinoid, has therapeutic effects and has been approved by the FDA for the treatment of two severe forms of pediatric epilepsy. Despite its widespread use for various indications, it can interact with common medications and substances such as acetaminophen and alcohol.

JOURNAL OF GENERAL INTERNAL MEDICINE (2021)

Review Clinical Neurology

The Role of Cannabidiol (CBD) in Chronic Pain Management: An Assessment of Current Evidence

Shafik Boyaji et al.

CURRENT PAIN AND HEADACHE REPORTS (2020)

Article Substance Abuse

CBD (Cannabidiol) Product Attitudes, Knowledge, and Use Among Young Adults

Meghann Wheeler et al.

SUBSTANCE USE & MISUSE (2020)

Article Substance Abuse

Sources of cannabis among young adults and associations with cannabis-related outcomes

Elizabeth J. D'Amico et al.

INTERNATIONAL JOURNAL OF DRUG POLICY (2020)

Article Pharmacology & Pharmacy

Labeling of Cannabidiol Products: A Public Health Perspective

Jamie Corroon et al.

CANNABIS AND CANNABINOID RESEARCH (2020)

Review Pharmacology & Pharmacy

Lack of evidence for the effectiveness or safety of over-the-counter cannabidiol products

Edward Chesney et al.

THERAPEUTIC ADVANCES IN PSYCHOPHARMACOLOGY (2020)

Review Pharmacology & Pharmacy

A systematic review of cannabidiol dosing in clinical populations

S. A. Millar et al.

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2019)

Review Behavioral Sciences

How does cannabidiol (CBD) influence the acute effects of delta-9-tetrahydrocannabinol (THC) in humans? A systematic review

Abigail M. Freeman et al.

NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS (2019)

Review Neurosciences

Cannabidiol (CBD) use in psychiatric disorders: A systematic review

Stefania Bonaccorso et al.

NEUROTOXICOLOGY (2019)

Article Substance Abuse

Context matters: Characteristics of solitary versus social cannabis use

Toni C. Spinella et al.

DRUG AND ALCOHOL REVIEW (2019)

Article Pharmacology & Pharmacy

A Cross-Sectional Study of Cannabidiol Users

Jamie Corroon et al.

CANNABIS AND CANNABINOID RESEARCH (2018)

Letter Medicine, General & Internal

Labeling Accuracy of Cannabidiol Extracts Sold Online

Marcel O. Bonn-Miller et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2017)

Review Pharmacology & Pharmacy

An Update on Safety and Side Effects of Cannabidiol: A Review of Clinical Data and Relevant Animal Studies

Kerstin Iffland et al.

CANNABIS AND CANNABINOID RESEARCH (2017)

Article Pharmacology & Pharmacy

Preliminary Development of a Brief Cannabis Use Disorder Screening Tool: The Cannabis Use Disorder Identification Test Short-Form

Marcel O. Bonn-Miller et al.

CANNABIS AND CANNABINOID RESEARCH (2016)

Review Psychiatry

A systematic review of the antipsychotic properties of cannabidiol in humans

Tabitha A. Iseger et al.

SCHIZOPHRENIA RESEARCH (2015)

Article Clinical Neurology

The PHQ-8 as a measure of current depression in the general population

Kurt Kroenke et al.

JOURNAL OF AFFECTIVE DISORDERS (2009)

Article Medicine, General & Internal

A brief measure for assessing generalized anxiety disorder -: The GAD-7

Robert L. Spitzer et al.

ARCHIVES OF INTERNAL MEDICINE (2006)